ES8707731A1 - Oxindole antiinflammatory agents. - Google Patents

Oxindole antiinflammatory agents.

Info

Publication number
ES8707731A1
ES8707731A1 ES554609A ES554609A ES8707731A1 ES 8707731 A1 ES8707731 A1 ES 8707731A1 ES 554609 A ES554609 A ES 554609A ES 554609 A ES554609 A ES 554609A ES 8707731 A1 ES8707731 A1 ES 8707731A1
Authority
ES
Spain
Prior art keywords
oxindole
antiinflammatory agents
substituted
aminolysis
carboxamides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES554609A
Other languages
Spanish (es)
Other versions
ES554609A0 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/666,953 external-priority patent/US4644005A/en
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of ES554609A0 publication Critical patent/ES554609A0/en
Publication of ES8707731A1 publication Critical patent/ES8707731A1/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • C07D209/70—[b]- or [c]-condensed containing carbocyclic rings other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Ketone containing 1-substituted oxindole-3-carboxamides as antiinflammatory agents prepared by reaction of the 1-substituted oxindole with an isocyanate or by aminolysis of the corresponding alkyl oxindole-3-carboxylate.
ES554609A 1984-10-31 1986-04-30 Oxindole antiinflammatory agents. Expired ES8707731A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/666,953 US4644005A (en) 1984-10-31 1984-10-31 Oxindole antiinflammatory agents
US06/762,998 US4686224A (en) 1984-10-31 1985-08-06 Oxindole antiinflammatory agents

Publications (2)

Publication Number Publication Date
ES554609A0 ES554609A0 (en) 1987-08-16
ES8707731A1 true ES8707731A1 (en) 1987-08-16

Family

ID=27099577

Family Applications (1)

Application Number Title Priority Date Filing Date
ES554609A Expired ES8707731A1 (en) 1984-10-31 1986-04-30 Oxindole antiinflammatory agents.

Country Status (16)

Country Link
US (1) US4686224A (en)
EP (1) EP0181136B1 (en)
KR (1) KR870001269B1 (en)
AU (1) AU555051B2 (en)
CA (1) CA1247099A (en)
DE (1) DE3585719D1 (en)
DK (1) DK163990C (en)
ES (1) ES8707731A1 (en)
FI (1) FI81340C (en)
GR (1) GR852629B (en)
HU (1) HU194168B (en)
IE (1) IE58207B1 (en)
IL (1) IL76854A (en)
PH (3) PH20985A (en)
PL (2) PL145239B1 (en)
PT (1) PT81393B (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU215112B (en) * 1989-01-10 1998-12-28 Pfizer Inc. Process for producing antiphlogistic 1-heteroaryl-3-acyl-2-oxindole derivatives
US5128352A (en) * 1989-01-10 1992-07-07 Pfizer Inc. Anti-inflammatory 1-heteroaryl-oxindole-3-carboxamides
JPH0717589B2 (en) * 1990-01-22 1995-03-01 ファイザー製薬株式会社 Novel 1,3-dicarbonyl compound and composition thereof
CH687764A5 (en) * 1992-07-02 1997-02-14 Lonza Ag Gampel Wallis Geschof A process for the preparation of 7-Acylindolen.
US5449788A (en) * 1994-01-28 1995-09-12 Catalytica, Inc. Process for preparing 2-oxindole-1-carboxamides
GB9414139D0 (en) * 1994-07-13 1994-08-31 Smithkline Beecham Plc Novel compounds
US7855297B2 (en) * 2000-09-14 2010-12-21 Mitsubishi Tanabe Pharma Corporation Amide derivatives and medicinal use thereof
JP2004529110A (en) 2001-03-06 2004-09-24 アストラゼネカ アクチボラグ Indole derivatives with vascular damage activity
AU2002322720B2 (en) 2001-07-25 2008-11-13 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
WO2005041957A1 (en) * 2003-10-29 2005-05-12 Pfizer Products Inc. Oxindole derivatives and their use as phosphodiesterase type 2 inhibitors
EP2392258B1 (en) 2005-04-28 2014-10-08 Proteus Digital Health, Inc. Pharma-informatics system
MX2009002893A (en) 2006-09-18 2009-07-10 Raptor Pharmaceutical Inc Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates.
TR201908314T4 (en) 2009-02-20 2019-06-21 2 Bbb Medicines B V Glutathione based drug delivery system.
IL295075A (en) 2009-05-06 2022-09-01 Laboratory Skin Care Inc Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
CN104130176A (en) * 2014-06-13 2014-11-05 天津科技大学 1,5-disubstituted indolone derivative and application thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE756447A (en) * 1969-10-15 1971-03-22 Pfizer OXINDOLECARBOXAMIDES
US3749731A (en) * 1971-07-08 1973-07-31 Warner Lambert Co 2-oxo-n-(2-thiazolyl)-3-indoline-carboxamide
DE3114351A1 (en) * 1981-04-09 1982-11-04 Hoechst Ag, 6000 Frankfurt "OXINDOL DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING IT WITH A NEUROANABOLIC EFFECT"
AU8509882A (en) * 1981-06-30 1983-01-06 Merck & Co., Inc. Tricyclic derivatives of substituted pyrrole acids
DE3568776D1 (en) * 1984-02-07 1989-04-20 Pfizer 1,3-disubstituted 2-oxindoles as analgesic and anti-inflammatory agents
US4556672A (en) * 1984-03-19 1985-12-03 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
EP0155828B1 (en) * 1984-03-19 1990-09-19 Pfizer Inc. Process for making 2-oxindole-1-carboxamides and intermediates therefor

Also Published As

Publication number Publication date
PH20985A (en) 1987-06-18
IL76854A (en) 1989-05-15
DK163990B (en) 1992-04-27
IL76854A0 (en) 1986-02-28
PL255990A1 (en) 1987-03-23
ES554609A0 (en) 1987-08-16
DK163990C (en) 1992-09-21
IE58207B1 (en) 1993-07-28
PH24091A (en) 1990-03-05
EP0181136B1 (en) 1992-03-25
CA1247099A (en) 1988-12-20
PT81393A (en) 1985-11-01
PT81393B (en) 1988-02-17
EP0181136A2 (en) 1986-05-14
US4686224A (en) 1987-08-11
FI81340C (en) 1990-10-10
DK497685D0 (en) 1985-10-30
EP0181136A3 (en) 1987-10-28
HUT39428A (en) 1986-09-29
HU194168B (en) 1988-01-28
PL150842B1 (en) 1990-07-31
AU4918985A (en) 1986-05-08
KR860003260A (en) 1986-05-21
AU555051B2 (en) 1986-09-11
PH23130A (en) 1989-05-05
FI854258A0 (en) 1985-10-30
PL145239B1 (en) 1988-08-31
DE3585719D1 (en) 1992-04-30
PL262327A1 (en) 1987-11-02
KR870001269B1 (en) 1987-06-30
FI81340B (en) 1990-06-29
DK497685A (en) 1986-05-01
FI854258L (en) 1986-05-01
IE852703L (en) 1986-04-30
GR852629B (en) 1986-03-04

Similar Documents

Publication Publication Date Title
ES8707731A1 (en) Oxindole antiinflammatory agents.
ES8701737A1 (en) Substituted quinazolinediones.
AP8800109A0 (en) "Heterocyclic insecticides".
AU8181782A (en) Electrolyzer for the production of hydrogen
ES8400401A1 (en) Process for producing substituted pyrroles.
AU2700988A (en) N-hydroxy-5-phenyl-2-furancarboximidamides useful as cardiotonic agents
SU1269296A1 (en) Herbicide composition
SU778314A1 (en) Aluminum-based alloy
AU553641B2 (en) Regulated d.c. power supply
SU1133890A1 (en) Aluminum-based casting alloy
SU928823A1 (en) Aluminum-based alloy
SU1251528A1 (en) Film-substrate for cultivating animal cells
SU1051923A1 (en) Composition for coatings
SU1167881A1 (en) Fenylhydrazide of morpholinediethylacetic acid
SU1075725A1 (en) Antifreeze
AU6972481A (en) 6-pyridyl-pyridazinones useful as cardiotonic agents
SU1271275A1 (en) Matrix autoelectron cathode
SU1269688A1 (en) Ion source
SU1244928A1 (en) Method of obtaining cis-1,4-polybutadiene
SU1253113A1 (en) Method of obtaining cis-1,4-polybutadiene
SU1208765A1 (en) Method of obtaining phenolxyphenylcarbamide
ES8308857A1 (en) 5-Oxymethyl-4-acyl-1,3-dihydro-2H-imidazol-2-ones.
SU999919A1 (en) Chemical gas laser
SU1264575A1 (en) Method of cell immobilization
SU1172285A1 (en) Aluminum-based alloy

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20020401